This study identified eighteen pathogenic RB1 variants (2 missense, 7 stop gain, 1 splice donor, 8 frameshift variants) using targeted amplicon sequencing among 49 (37%) RB patients. This evidence concerns the gene RB1 and retinoblastoma.